Integration of Three-Dimensional Scar Maps for Ventricular Tachycardia Ablation With Positron Emission Tomography-Computed Tomography

JACC: Cardiovascular Imaging

Volumn 1, Issue 1, 2008, Pages 73-82

  Dickfeld, Timm ^a,b   Lei, Peng ^a   Dilsizian, Vasken ^a   Jeudy, Jean ^a   Dong, Jun ^b   Voudouris, Apostolos ^a   Peters, Robert ^a   Saba, Magdi ^a   Shekhar, Raj ^a   Shorofsky, Stephen ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FLUORODEOXYGLUCOSE F 18; GLUCOSE; IOHEXOL; SOTALOL;

ACCURACY; ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CATHETER ABLATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; EPICARDIUM MAPPING; FEMALE; HEART INFARCTION; HEART MUSCLE BLOOD FLOW; HEART VENTRICLE TACHYCARDIA; HUMAN; IMAGE QUALITY; IMAGE RECONSTRUCTION; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; THREE DIMENSIONAL IMAGING;

AGED; CATHETER ABLATION; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; ENDOCARDIUM; FEASIBILITY STUDIES; FEMALE; HEART VENTRICLES; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MALE; MIDDLE AGED; MYOCARDIUM; PERICARDIUM; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; SURGERY, COMPUTER-ASSISTED; TACHYCARDIA, VENTRICULAR; TOMOGRAPHY, X-RAY COMPUTED;

EID: 41249088218     PISSN: 1936878X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcmg.2007.10.001     Document Type: Article

References (28)

1. Kadish A., Dyer A., Daubert J.P., et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350 (2004) 2151-2158
2. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
3. Marchlinski F.E., Callans D.J., Gottlieb C.D., and Zado E. Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. Circulation 101 (2000) 1288-1296
4. Soejima K., Suzuki M., Maisel W.H., et al. Catheter ablation in patients with multiple and unstable ventricular tachycardias after myocardial infarction: short ablation lines guided by reentry circuit isthmuses and sinus rhythm mapping. Circulation 104 (2001) 664-669
5. Stevenson W.G., Friedman P.L., Kocovic D., Sager P.T., Saxon L.A., and Pavri B. Radiofrequency catheter ablation of ventricular tachycardia after myocardial infarction. Circulation 98 (1998) 308-314
6. Oza S., and Wilber D.J. Substrate-based endocardial ablation of postinfarction ventricular tachycardia. Heart Rhythm 3 (2006) 607-609
7. Verma A., Marrouche N.F., Schweikert R.A., et al. Relationship between successful ablation sites and the scar border zone defined by substrate mapping for ventricular tachycardia post-myocardial infarction. J Cardiovasc Electrophysiol 16 (2005) 465-471
8. Shekhar R., Walimbe V., Raja S., et al. Automated 3-dimensional elastic registration of whole-body PET and CT from separate or combined scanners. J Nucl Med 46 (2005) 1488-1496
9. Cerqueira M.D., Weissman N.J., Dilsizian V., et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105 (2002) 539-542
10. Dong J., Calkins H., Solomon S.B., et al. Integrated electroanatomic mapping with three-dimensional computed tomographic images for real-time guided ablations. Circulation 113 (2006) 186-194
11. Kim R.J., Fieno D.S., Parrish T.B., et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100 (1999) 1992-2002
12. Lima J.A., Judd R.M., Bazille A., Schulman S.P., Atalar E., and Zerhouni E.A. Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms. Circulation 92 (1995) 1117-1125
13. Faris O.P., and Shein M. Food and Drug Administration perspective: magnetic resonance imaging of pacemaker and implantable cardioverter-defibrillator patients. Circulation 114 (2006) 1232-1233
14. Nazarian S., Roguin A., Zviman M.M., et al. Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 Tesla. Circulation 114 (2006) 1277-1284
15. Marckmann P., Skov L., Rossen K., et al. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 17 (2006) 2359-2362
16. Buecker A., Katoh M., Krombach G.A., et al. A feasibility study of contrast enhancement of acute myocardial infarction in multislice computed tomography: comparison with magnetic resonance imaging and gross morphology in pigs. Invest Radiol 40 (2005) 700-704
17. Gerber B.L., Belge B., Legros G.J., et al. Characterization of acute and chronic myocardial infarcts by multidetector computed tomography: comparison with contrast-enhanced magnetic resonance. Circulation 113 (2006) 823-833
18. Czernin J., Porenta G., Brunken R., et al. Regional blood flow, oxidative metabolism, and glucose utilization in patients with recent myocardial infarction. Circulation 88 (1993) 884-895
19. Yoshida K., and Gould K.L. Quantitative relation of myocardial infarct size and myocardial viability by positron emission tomography to left ventricular ejection fraction and 3-year mortality with and without revascularization. J Am Coll Cardiol 22 (1993) 984-997
20. de Silva R., Yamamoto Y., Rhodes C.G., et al. Preoperative prediction of the outcome of coronary revascularization using positron emission tomography. Circulation 86 (1992) 1738-1742
21. Perrone-Filardi P., Bacharach S.L., Dilsizian V., et al. Clinical significance of reduced regional myocardial glucose uptake in regions with normal blood flow in patients with chronic coronary artery disease. J Am Coll Cardiol 23 (1994) 608-616
22. Dickfeld T., Calkins H., Zviman M., et al. Anatomic stereotactic catheter ablation on three-dimensional magnetic resonance images in real time. Circulation 108 (2003) 2407-2413
23. Dickfeld T., Calkins H., Zviman M., et al. Stereotactic magnetic resonance guidance for anatomically targeted ablations of the fossa ovalis and the left atrium. J Interv Card Electrophysiol 11 (2004) 105-115
24. Reddy V.Y., Malchano Z.J., Holmvang G., et al. Integration of cardiac magnetic resonance imaging with three-dimensional electroanatomic mapping to guide left ventricular catheter manipulation: feasibility in a porcine model of healed myocardial infarction. J Am Coll Cardiol 44 (2004) 2202-2213
25. Solomon S.B., Dickfeld T., and Calkins H. Real-time cardiac catheter navigation on three-dimensional CT images. J Interv Card Electrophysiol 8 (2003) 27-36
26. Sra J., Krum D., Belanger B., and Vaillant R. Registration of three-dimensional left atrial computed tomographic images with fluoroscopy. Heart Rhythm 2 (2005) 1020
27. Dickfeld T., Calkins H., Bradley D., and Solomon S.B. Stereotactic catheter navigation using magnetic resonance image integration in the human heart. Heart Rhythm 2 (2005) 413-415
28. Wilber D.J., Kopp D.E., Glascock D.N., Kinder C.A., and Kall J.G. Catheter ablation of the mitral isthmus for ventricular tachycardia associated with inferior infarction. Circulation 92 (1995) 3481-3489